Phoenix, Oct. 05, 2016 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (PINKSHEETS: ONOV) is pleased to share the latest very successful test results of its bio-fungicide CR-10, in the fight against coffee leaf rust (Hemileia vastatrix or “roya” in Spanish) in Costa Rica and Guatemala.
BioNovelus is fighting the ongoing battle against coffee rust with our eco-friendly, 100% biodegradable CR-10, in Guatemala and Costa Rica. By putting our product directly into the hands of coffee growers for testing, and agronomic engineers to fight this fungus, our product brought the rust from 75% infection rate down to 40% in just one application in 21 days in a farm in the region of Antigua, in Guatemala. In other battlefields against coffee rust, CR-10 has gone down from 71% to 20% in one application over a period of 11 weeks, and from 73% to 34.5% in one application over a period of 27 days, in two farms in the region of Coto Brus, in Costa Rica. These are the newest results we have received from our hands-on test partners. The test results are also showing that if you use 2-3 applications, the affectation can be under control (which is under 10%).
Along with this amazing success rate, CR-10 is also currently undergoing more studies by agronomic engineers and both the Guatemalan and Costa Rican national coffee associations, Anacafé and ICafé. Based on preliminary tests, management believes that these studies will allow growers to go from having diseased plants to healthy plants which yield more fruit and more income from their harvests.
Farmers suffering from coffee rust currently have the following choices:
#1. They can choose to prune the plants down to the root (realizing what farmers call a “poda total” in Spanish) or plant the new hybrid or GMO plants, yet they have a 3-4 years to wait for a mature plant in order to bear fruit.
#2. The can use chemicals on the plants which negatively affects both the yield and the life-force of the plant. This also affects the taste and, of course, damages the soil greatly.
#3. They can decide to stop growing coffee, and start growing more rewarding less demanding crops.
BioNovelus’ CR-10 gives a solution that is not only eco-friendly and non-toxic (when used at recommended dilution) but allows the farmers to save a majority of their infected plants within one growing cycle. In addition, the harvest can still yield a closer result to their original intended potential crop, since the plant’s life-force is restored. This provides the growers with a unique viable “green”, and sustainable solution.
BioNovelus is working diligently with the government officials to get the products registered, so that the growers in Central America will be able to purchase this fungicide for the new growing season.
About BioNovelus Inc.
BioNovelus, Inc. (PINKSHEETS: ONOV) is a bioscience company that honors the environment with an innovative, cost effective and disruptive technology-based solution to agricultural and water problems.
We are determined to help coffee growers keep the better tasting strain of the Arabica plant by fighting coffee rust through our “green” CR-10 instead of being forced to change to “hybrid” type plants. We feel very strongly that our “green”, biodegradable product is not only better for our environment but for people who enjoy the rich flavor that comes from Arabica coffee beans, whether organic or not.
BioNovelus’ primary target market is the $100Billion* plus, annual, worldwide, coffee industry. (*Source: Business Insider) Coffee Rust or "Roya" (Hemileia vastatrix), is a devastating fungus attacking the Arabica plant, currently, the coffee industry’s greatest threat. Billions of dollars and hundreds of thousands of industry jobs have been lost throughout Central America since 2012. (Source: ICafé)
This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events.
Factors that could cause the Company’s results to differ materially from forward looking statements regarding the efficacy of the crop restoration and results of CR-10 and registration approval include the lack of capital needed to complete testing, the lack of experience with pursuing approval of this product and modifications and receipt of information that may be demanded by the registration of the CR-10 formula and the delays in the various government approval processes unrelated to the product itself. Factors that could cause lower rates of success in CR-10 eradication of fungi include the method and timing of applications of CR-10, the impact of heavy rainfall the strength of fungi contamination, and other environmental conditions resulting in re-infection.
Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, general business and economic conditions beyond the Company's control the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and the Company's success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
For additional information: http://bionovelus.com
Last updated on: 06/10/2016
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.